Peppers and pain. The promise of capsaicin

Drugs

Volumn 53, Issue 6, 1997, Pages 909-914

  Fusco, Bruno M ^a   Giacovazzo, Mario ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CAPSAICIN; PLANT EXTRACT;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; CLINICAL TRIAL; CLUSTER HEADACHE; DESENSITIZATION; DIABETIC NEUROPATHY; DRUG MECHANISM; HUMAN; META ANALYSIS; MYALGIA; NEUROGENIC INFLAMMATION; NOCICEPTION; NONHUMAN; NOSE MUCOSA; OSTEOARTHRITIS; POSTHERPETIC NEURALGIA; SENSORY NERVE CELL; TOPICAL DRUG ADMINISTRATION;

ANIMALIA; CAPSICUM; CAPSICUM ANNUUM VAR. ANNUUM;

EID: 0030906860     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199753060-00001     Document Type: Article

References (37)

1. Hua XY, Saria A, Gamse R, et al. Multiple tachykinins (neurokinin A, neuropeptide Y, and substance P) in capsaicin-sensitive neurons in guinea-pig. Regul Pept 1985; 133: 1-19
2. Burgess PR, Perl PR. Myelinated afferent fibres responding specifically to noxious stimulation of the skin. J Physiol (Lond) 1967; 190: 541-62
3. Szolcziany J. Antidromic vasodilation and neurogenic inflammation. Agents Actions 1988; 23: 4-11
4. Lembeck F. Sir Thomas Lewis's nocifensor system, histamine and substance P containing primary afferent nerves. Trends Neurol Sci 1983; 6: 106-8
5. Jancso G, Kiraly E, Jancso-Gabor A. Pharmacologically induced selective degeneration of chemosensensitive primary sensory neurons. Nature 1977; 270: 741-3
6. Jancso G, Kiraly E, Jancso-Gabor A, et al. Direct evidence for an axonal site of action of capsaicin. Naunyn Schmiedebergs Arch Pharmacol 1980; 313: 91-4
7. Nagy I, Maggi CA, Dray A, et al. The role of neurokinin and N-methyl-D aspartate receptors in synaptic transmission form capsaicin-sensitive primary afferent in the rat spinal cord in vitro. Neuroscience 1993; 52: 1029-37
8. Maggi CA, Santicioli P, Geppetti P, et al. Simultaneous release of substance P and calcitonin gene-related peptide (CGRP)-like immunoreactivity from isolated muscle of the guinea pig urinary bladder. Neurosci Lett 1988; 87: 163-7
9. Maggi CA, Santicioli P, Geppetti P, et al. Regional differences in the motor response to capsaicin of the guinea-pig urinary bladder: relative role of pre and postjunctional factors related to neuropeptide-containing sensory nerves. Neuroscience 1988; 31: 375-82
10. Geppetti P, Tramontana M, Evangelista S, et al. Differential effect on neuropeptide release of different concentrations of hydrogen ions on afferent and intrinsic neurons of the rat stomach. Gastroenterology 1991; 101: 1505-11
11. Jancso N. Desensitization with capsaicin and related acylamides as a tool for studying the function of pain receptors. In: Lin Kill D Armstrong, Pardo EG, editors. Pharmacology of pain. Vol. 9. Oxford: Pergamon Press, 1968: 33
12. Szallasi A, Blumberg PM. Specific binding of resinoferatoxin, an ultrapotent capsaicin analog, by dorsal root ganglion membranes. Brain Res 1990; 524: 106-11
13. Szallasi A, Blumberg PM. Mechanisms and therapeutic potential of vanilloids (capsaicin-like molecules). Adv Pharmacol 1993; 24: 123-55
14. Holtzer P, Bucsics A, Lembeck F. Distribution of (capsaicin-sensitive nerve fibres containing immunoreactive substance P) in cutaneous and visceral tissues of the rat. Neurosci Lett 1982; 31: 253-7
15. Szallasi A. The vanilloid (capsaicin) receptor: receptor type and species differences. Gen Pharmacol 1994; 25: 223-43
16. Buck S, Burks T. The neuropharmacology of capsaicin: review of some recent observations. Pharmacol Rev 1986; 38: 179-216
17. Buck S, Miller MS, Burks TF. Depletion of primary afferent substance Pby capsaicin without altered thermal sensitivity in rats. Brain Res 1982; 233: 216-20
18. P Geppetti, BM Fusco, M Alessandri, et al. Kallidin applied to the human nasal mucosa produces algesic response not blocked by capsaicin desensitization. Regul Pept 1991; 33: 321-9
19. Simone D, Ochoa J. Early and late effects of prolonged topical capsaicin on cutaneous sensibility and neurogenic vasodilation in humans. Pain 1991; 47: 285-94
20. Carpenter SE, Lynn B. Vascular and sensory responses of human skin to mild injury after topical treatment with capsaicin. Br J Pharmacol 1981; 33: 755-8
21. Geppetti P, Fusco BM, Marabini S, et al. Secretion, pain and sneezing induced by application of capsaicin to the nasal mucosa in man. Br J Pharmacol 1987; 93: 509-14
22. Jancso G, Lynn B. Possible use of capsaicin in pain therapy. Clin J Pain 1987; 3: 123-6
23. Lynn B. Actions on nociceptive C-fibers and therapeutical potential. Pain 1990; 41: 61-9
24. Sjolund BH, Erickson MBE. Stimulation techniques in the management of pain. In: Kosterlitz H, Terenius L, editors. Pain and society. London: Verlac Chemie, 1980: 415
25. Bernstein JE, Bickers DR, Dahl MV, et al. Treatment of chronic postherpetic neuralgia with topical capsaicin. J Am Acad Dermatol 1987; 17: 93-6
26. Watson CPN, Evans RJ, Watt VR. Post-herpetic neuralgia and topical capsaicin. Pain 1988; 33: 333-40
27. Watson CPN, Evans RJ, Watt VR. The post mastectomy pain syndrome and the effect of topical capsaicin. Pain 1989; 38: 177-86
28. Ross DR, Varipapa RJ. Treatment of painful diabetic neuropathy with topical capsaicin. N Engl J Med 1989; 321: 474-5
29. Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin. Arch Intern Med 1991; 151: 2225-9
30. Fusco BM, Alessandri M. Effect of topical application of capsaicin in trigeminal neuralgia. Anesth Analg 1992; 74: 375-7
31. Deal CL, Schnitzer TJ, Lipstein E, et al. Treatment of arthritis with topical capsaicin: a double blind trial. Clin Ther 1991; 13: 383-95
32. Cheshire WP, Snyder CR. Treatment of reflex sympathetic dystrophy with topical capsaicin. Case report. Pain 1990; 42: 307-11
33. Wallengren J. Treatment of notalgia paresthetica with topical capsaicin. J Am Acad Dermatol 1990; 24: 286-8
34. Wallengren J, Klinker M. Successful treatment of notalgia paresthetica with topical capsaicin vehicle. Controlled, double blind, crossover study. J Am Acad Dermatol 1995; 32: 287-9
35. Morgelander JC, Hurwitz BJ, Massy W. Capsaicin for the treatment of pain in Guillain-Barré syndrome. Ann Neurol 1990; 28: 199
36. Fusco BM, Marabini S, Maggi CA, et al. Preventative effect of repeated nasal applications of capsaicin in cluster headache. Pain 1994; 59: 321-5
37. Berger A, Henderson M, Nadoolman W, et al. Oral capsaicin provides temporary relief for oral mucositis pain secondary to chemotherapy/radiation therapy. J Pain Symptom Manage 1995; 10 (3): 243-8